Article

Antenatal ureaplasma infection impairs development of the fetal ovine gut in an IL-1-dependent manner.

1] Department of Neonatology, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, Ohio, USA [2] Department of Pediatrics, Maastricht University Medical Center (MUMC), School of Oncology and Developmental Biology (GROW), Maastricht, The Netherlands.
Mucosal Immunology (Impact Factor: 7.54). 11/2012; DOI: 10.1038/mi.2012.97
Source: PubMed

ABSTRACT Ureaplasma infection of the amniotic cavity is associated with adverse postnatal intestinal outcomes. We tested whether interleukin-1 (IL-1) signaling underlies intestinal pathology following ureaplasma exposure in fetal sheep. Pregnant ewes received intra-amniotic injections of ureaplasma or culture media for controls at 3, 7, and 14 d before preterm delivery at 124 d gestation (term 150 d). Intra-amniotic injections of recombinant human interleukin IL-1 receptor antagonist (rhIL-1ra) or saline for controls  were given 3 h before and every 2 d after Ureaplasma injection. Ureaplasma exposure caused fetal gut inflammation within 7 d with damaged villus epithelium and gut barrier loss. Proliferation, differentiation, and maturation of enterocytes were significantly reduced after 7 d of ureaplasma exposure, leading to severe villus atrophy at 14 d. Inflammation, impaired development and villus atrophy of the fetal gut was largely prevented by intra-uterine rhIL-1ra treatment. These data form the basis for a clinical understanding of the role of ureaplasma in postnatal intestinal pathologies.Mucosal Immunology advance online publication 14 November 2012; doi:10.1038/mi.2012.97.

0 Followers
 · 
129 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background:Gut immaturity is linked with postnatal intestinal disorders. However, biomarkers to assess the intestinal developmental stage around birth are lacking. The aim of this study was to gain more insight on intestinal-fatty acid binding protein (I-FABP) as indicator of gut maturity.Methods:Antenatal I-FABP distribution and release was investigated in extremely premature, moderately premature and term lambs and these findings were verified in urinary human samples. Ileal I-FABP distribution was confirmed in autopsy material within 24h postnatally.Results:Median (range) serum I-FABP levels were lower in extremely premature lambs compared to moderately premature lambs (156 (50.0-427) vs. (385 (100-1,387) pg/ml, p=0.02). Contrarily, median early postnatal urine I-FABP levels in human infants were higher in extremely premature compared to moderately premature and term neonates (1,219 (203-15,044) vs. 256 (50-1,453) and vs. 328 (96-1,749) pg/ml, p=0.008 and p=0.04, respectively). I-FABP expression was most prominent in non-vacuolated enterocytes and increased with rising gestational age in ovine and human tissue samples. The epithelial distribution pattern changed from a phenotype displaying I-FABP positive enterocytes merely in the crypts early in gestation into a phenotype with I-FABP expressing cells exclusively present in the villus tips at term in ovine and human tissue.Conclusion:In this ovine and human study, increasing gestational age is accompanied by an increase in I-FABP tissue content. Cord I-FABP levels correlate with gestation in ovine fetuses identifying I-FABP as a marker for gut maturation. Raised postnatal urine I-FABP levels in preterm human infants may indicate intestinal injury and/or inflammation in utero.Pediatric Research (2014); doi:10.1038/pr.2014.89.
    Pediatric Research 06/2014; DOI:10.1038/pr.2014.89 · 2.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency among premature infants. Although a large body of research has focused on understanding its pathogenesis, the exact mechanism has not been elucidated. Of particular interest is the potential causative role of infectious culprits in the development of NEC. A variety of reports describe bacterial, viral, and fungal infections occurring in association with NEC; however, no single organism has emerged as being definitively involved in NEC pathogenesis. In this review, the authors summarize the literature on infectious causes of NEC. Copyright © 2015 Elsevier Inc. All rights reserved.
    Clinics in Perinatology 03/2015; 42(1):133-154. DOI:10.1016/j.clp.2014.10.012 · 2.13 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: While critical for normal development, the exact timing of establishment of the intestinal microbiome is unknown. For example, although preterm labor and birth have been associated with bacterial colonization of the amniotic cavity and fetal membranes for many years, the prevailing dogma of a sterile intra-uterine environment during normal term pregnancies has been challenged more recently. While found to be a key contributor of evolution in the animal kingdom, maternal transmission of commensal bacteria may also constitute a critical process during healthy pregnancies in humans with yet unclear developmental importance. Metagenomic sequencing has elucidated a rich placental microbiome in normal term pregnancies likely providing important metabolic and immune contributions to the growing fetus. Conversely, an altered microbial composition during pregnancy may produce aberrant metabolites impairing fetal brain development and life-long neurological outcomes. Here we review the current understanding of microbial colonization at the feto-maternal interface and explain how normal gut colonization drives a balanced neonatal mucosal immune system, while dysbiosis contributes to aberrant immune function early in life and beyond. We discuss how maternal genetics, diet, medications and probiotics inform the fetal microbiome in preparation for perinatal and postnatal bacterial colonization.Pediatric Research (2014); doi:10.1038/pr.2014.163.
    Pediatric Research 10/2014; 77(1-2). DOI:10.1038/pr.2014.163 · 2.84 Impact Factor